Search

September 20, 2024, Medical Economics
Malpractice Caps and Nuclear Verdicts
Medical Economics Editorial Director Chris Mazzolini sits down with Bob White, President of The Doctors Company and TDC Group, to discuss trends in malpractice litigation and what recent verdicts mean for the industry at large.

December 11, 2023, Part B News
Thwart Abuse: Consider Opt-out,Training in Chaperone Policy
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides policy suggestions for healthcare providers to implement that can help defend against sexual harassment allegations.

November 01, 2023, Healthcare Risk Management
How to Identify and Defend Against Malicious Lawsuits
Richard F. Cahill, Esq., Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses common concerns healthcare professionals have when it comes to disgruntled patients and malicious lawsuits.

March 05, 2024, Business Insurance
Alabama Embryo Ruling May Increase Med Mal Risks
Robert White, President of The Doctors Company and TDC Group, discusses the potential impacts the recent IVF ruling in Alabama will have on healthcare professionals.

The Doctors Company Assists Members Impacted by Hurricanes Helene and Milton
Due to disruption to member medical practices from Hurricanes Helene and Milton and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee.

Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Stay in the Know

Our e-newsletters feature timely articles, videos, and guides on a range of patient safety topics.

The Doctor’s Practice

Medical Icon Clipart Subscribe

The Dentist’s Advocate

Tooth Clipart Subscribe

The Practitioner

Man and Two Women Doctors Clipart Subscribe